Topics
Gliomas | Treatment | Targeted therapy | Pritumumab
Home > Publications > Topics > Gliomas > Treatment > Targeted therapy > Pritumumab
Carrillo J, Gill JM, Redfern C, Babic I, Nomura N, Shah DK,
Carrick S, Kesari S.
A phase 1 dose
escalation of pritumumab in patients with refractory or
recurrent gliomas or brain
metastases.
Neurooncol
Adv. 2024 Sep 30;6(1):vdae166. doi:
10.1093/noajnl/vdae166. PMID:
39465217. Interventional study. ˍ